Vigmed CEO sells shares within the family

Finn Ketler, CEO of Vigmed Holding AB, has sold 670,000 shares (1/3 of total ownership) in the Company to his father, Kristian Iversen. The primary reason for this sale is that the loan Finn Ketler took to finance the acquisition of the shares before he became CEO, is due.

When Finn Ketler took over as CEO of Vigmed in April 2012, he was invited by the principal shareholders to purchase shares in the Company at market price. Linked to the offer was also an offer of a loan from the sellers of the shares, at market conditions. The term of this loan was three years and it is now due for payment. Due to personal financial consideration, Finn Ketler has chosen to sell 670,000 shares to his father, Kristian Iversen.

For further information contact:

Chairman of the board, Lennart Holm 46 70 630 8562 

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor